Tandem Diabetes Care (MEX:TNDM) Change In Receivables: MXN-821 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TNDM Tandem Diabetes Care Inc MEX:TNDM
69 GF Score
Price MXN745.00
GF Value MXN835.73
! 6 Warning Signs
View Full Analysis

What is Tandem Diabetes Care Change In Receivables?

Tandem Diabetes Care MEX:TNDM 69 Change In Receivables is MXN-821 Mil as of Jun. 2026. GuruFocus rates MEX:TNDM with a GF Score™ of 69/100 and a GF Value™ of MXN835.73. The stock has 6 warning signs investors should review.

Tandem Diabetes Care's change in receivables for the quarter that ended in Jun. 2026 was MXN-450 Mil. It means Tandem Diabetes Care's Accounts Receivable increased by MXN450 Mil from Mar. 2026 to Jun. 2026 .

Tandem Diabetes Care's change in receivables for the fiscal year that ended in Dec. 2025 was MXN-1,023 Mil. It means Tandem Diabetes Care's Accounts Receivable increased by MXN1,023 Mil from Dec. 2024 to Dec. 2025 .

Tandem Diabetes Care's Accounts Receivable for the quarter that ended in Jun. 2026 was MXN2,828 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tandem Diabetes Care's Days Sales Outstanding for the three months ended in Jun. 2026 was 58.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tandem Diabetes Care's liquidation value for the three months ended in Jun. 2026 was MXN-6,608 Mil.

Tandem Diabetes Care  (MEX:TNDM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tandem Diabetes Care's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2827.872/4441.817*91
=58.09

2. In Ben Graham's calculation of liquidation value, Tandem Diabetes Care's accounts receivable are only considered to be worth 75% of book value:

Tandem Diabetes Care's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7956.674-17864.53+0.75 * 2827.872+0.5 * 2357.465
=-6,608

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care Change In Receivables Related Terms

Tandem Diabetes Care Change In Receivables Historical Data

* Premium members only.

The historical data trend for Tandem Diabetes Care's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care Change In Receivables Chart

Tandem Diabetes Care Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -635.52 -152.65 72.60 -433.69 -1,022.94

Tandem Diabetes Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.33 -23.52 -756.49 408.98 -449.52
MEX:TNDM
69GF Score
Tandem Diabetes Care Inc MEX:TNDM
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tandem Diabetes Care Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-821 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of MXN-821 Mil mean?
Tandem Diabetes Care (MEX:TNDM) has a Change In Receivables of MXN-821 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Tandem Diabetes Care and its competitors.
Is Tandem Diabetes Care's Change In Receivables too high?
Tandem Diabetes Care's current Change In Receivables is MXN-821 Mil. Overall, Tandem Diabetes Care has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Tandem Diabetes Care's Change In Receivables compare to AVNS and IRMD?
Tandem Diabetes Care's Change In Receivables of MXN-821 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Tandem Diabetes Care and its competitors. Tandem Diabetes Care's current Change In Receivables is MXN-821 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tandem Diabetes Care stock overvalued right now?
Tandem Diabetes Care (MEX:TNDM) has a current Change In Receivables of MXN-821 Mil. The stock's GF Value™ is MXN835.73, compared to a current price of MXN745.00 — trading 10.9% below its estimated fair value. The current Change In Receivables is MXN-821 Mil. Tandem Diabetes Care's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Tandem Diabetes Care (MEX:TNDM), the current Change In Receivables is MXN-821 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tandem Diabetes Care (MEX:TNDM) Overvalued in 2026?

Based on GuruFocus' analysis, Tandem Diabetes Care stock appears to be undervalued. The current stock price of MXN745.00 is trading 10.9% below its estimated GF Value™ of MXN835.73.

Key valuation signals for MEX:TNDM:

  • Change In Receivables: MXN-821 Mil
  • GF Value™: MXN835.73 vs. price of MXN745.00 (10.9% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the MEX:TNDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tandem Diabetes Care Business Description

Address 12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
69GF Score

Get the complete analysis for MEX:TNDM

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN745.00
Price
MXN835.73
GF Value